Skip to main navigation Skip to search Skip to main content

Phase III randomized intergroup trial of CHOP plus rituximab compared with CHOP chemotherapy plus 131iodine-tositumomab for previously untreated follicular non-hodgkin lymphoma: SWOG S0016

  • Oliver W. Press
  • , Joseph M. Unger
  • , Lisa M. Rimsza
  • , Jonathan W. Friedberg
  • , Michael LeBlanc
  • , Myron S. Czuczman
  • , Mark Kaminski
  • , Rita M. Braziel
  • , Catherine Spier
  • , Ajay K. Gopal
  • , David G. Maloney
  • , Bruce D. Cheson
  • , Shaker R. Dakhil
  • , Thomas P. Miller
  • , Richard I. Fisher

Research output: Contribution to journal › Article › peer-review

156   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Phase III randomized intergroup trial of CHOP plus rituximab compared with CHOP chemotherapy plus 131iodine-tositumomab for previously untreated follicular non-hodgkin lymphoma: SWOG S0016'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science